Boai NKY Pharmaceuticals Ltd Cash Flow Reinvestment Rate
Boai NKY Pharmaceuticals Ltd cash flow reinvestment rate. Boai NKY Pharmaceuticals Ltd (300109) has a Cash Flow Reinvestment Rate of 0.30x as of September 2025, reinvesting CN¥41.41 Million (capex CN¥41.41 Million ) from operating cash flow of CN¥139.46 Million. Explore Boai NKY Pharmaceuticals Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Boai NKY Pharmaceuticals Ltd (2007–2025)
Cash flow reinvestment rate of Boai NKY Pharmaceuticals Ltd from 2007 to 2025. Historical reinvestment intensity for Boai NKY Pharmaceuticals Ltd across 18 annual periods. Explore 300109 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Boai NKY Pharmaceuticals Ltd Cash Flow Reinvestment Rate by Year (2007–2025)
Boai NKY Pharmaceuticals Ltd cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for Boai NKY Pharmaceuticals Ltd. For the full cash flow conversion analysis, see Boai NKY Pharmaceuticals Ltd cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥265.14 Million | CN¥338.11 Million | CN¥220.42 Million | ▼ -42.6% |
| 2024 | 1.37x | CN¥349.68 Million | CN¥256.03 Million | CN¥274.68 Million | ▼ -27.7% |
| 2023 | 1.89x | CN¥922.52 Million | CN¥488.25 Million | CN¥377.88 Million | ▲ +70.8% |
| 2022 | 1.11x | CN¥278.44 Million | CN¥251.77 Million | CN¥266.00 Million | ▼ -89.6% |
| 2021 | 10.68x | CN¥463.85 Million | CN¥43.44 Million | CN¥228.32 Million | ▲ +2487.3% |
| 2020 | 0.41x | CN¥110.14 Million | CN¥266.87 Million | CN¥99.24 Million | ▼ -85.8% |
| 2019 | 2.91x | CN¥231.96 Million | CN¥79.64 Million | CN¥142.35 Million | ▼ -60.7% |
| 2018 | 7.41x | CN¥361.81 Million | CN¥48.81 Million | CN¥124.37 Million | ▼ -11.8% |
| 2017 | 8.40x | CN¥397.23 Million | CN¥47.28 Million | CN¥129.23 Million | ▲ +509.6% |
| 2016 | 1.38x | CN¥157.33 Million | CN¥114.14 Million | CN¥48.47 Million | ▲ +118.3% |
| 2015 | 0.63x | CN¥40.48 Million | CN¥64.12 Million | CN¥40.48 Million | ▼ -37.6% |
| 2014 | 1.01x | CN¥47.11 Million | CN¥46.60 Million | CN¥47.11 Million | ▼ -34.0% |
| 2013 | 1.53x | CN¥35.47 Million | CN¥23.17 Million | CN¥35.47 Million | ▼ -65.3% |
| 2012 | 4.41x | CN¥90.96 Million | CN¥20.65 Million | CN¥90.96 Million | ▼ -83.4% |
| 2011 | 26.46x | CN¥104.29 Million | CN¥3.94 Million | CN¥104.29 Million | ▲ +1144.2% |
| 2010 | 2.13x | CN¥21.38 Million | CN¥10.05 Million | CN¥21.38 Million | ▲ +140.5% |
| 2009 | 0.88x | CN¥25.27 Million | CN¥28.57 Million | CN¥25.27 Million | ▲ +77.3% |
| 2007 | 0.50x | CN¥4.77 Million | CN¥9.56 Million | CN¥4.77 Million | — |